Photo by Viktor Forgacs on Unsplash

Zero new cases of COVID-19 are announced in Nova Scotia today (Monday, March 15).

There are 17 known active cases in the province. One person is in hospital with the disease, and that person is in ICU.

The active cases are distributed as follows:

• 3 in the Halifax Peninsula / Chebucto Community Health Network in the Central Zone
• 1 in the Dartmouth/ Southeastern Community Health Network in the Central Zone
• 6 in the Bedford/Sackville Community Health Network in the Central Zone
• 1 in the Cumberland Community Health Network in the Northern Zone
• 6 in the Annapolis and Kings Community Health Network in the Western Zone

Nova Scotia Health labs completed 1,667 tests yesterday.

Pop-up testing has been scheduled for the following locations:

Friday: Dalhousie University Goldberg Building, noon-7:30pm
Saturday: Dalhousie University Goldberg Building, 11am-6pm

You can also get tested at the Nova Scotia Health labs by going here.

As of end of day yesterday, 48,077 doses of vaccine have been administered — 31,964 first doses and 16,113 second doses.

Here are the new daily cases and seven-day rolling average (today at 1.6) since the start of the second wave (Oct. 1):

And here is the active caseload for the second wave:

The Halifax Examiner is an advertising-free, subscriber-supported news site. Your subscription makes this work possible; please subscribe.

Some people have asked that we additionally allow for one-time donations from readers, so we’ve created that opportunity, via the PayPal button below. We also accept e-transfers, cheques, and donations with your credit card; please contact iris “at” halifaxexaminer “dot” ca for details.

Thank you!

Tim Bousquet is the editor and publisher of the Halifax Examiner. Twitter @Tim_Bousquet Mastodon

Leave a comment

Only subscribers to the Halifax Examiner may comment on articles. We moderate all comments. Be respectful; whenever possible, provide links to credible documentary evidence to back up your factual claims. Please read our Commenting Policy.